B+
Bull case
20%
Probability
Target price
$14.00
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
PHAR
Pharming GroupBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Joenja is the strongest operating driver: Q2 revenue increased 40% year over year, U.S. paid patients reached 132, and European and Japanese launches broaden the commercial footprint.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
2026 revenue guidance was reduced to US$375m-US$395m, with no further specific financial guidance provided [#PR-2026-07-30].
Momentum
65
Value
62
Sentiment
66
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $11.50 · Bull $14.00 · Bear $8.75Analysis 2026-07-31; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-31 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $30.48
Why
Momentum65 · Δ7d -
Value62 · Δ7d 0.0
Sentiment66 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • 2026 revenue guidance was reduced to US$375m-US$395m, with no further specific financial guidance provided [#PR-2026-07-30].
- • CVID and broader PID readouts are clinical-risk events and could fail to support label expansion or commercial broadening [#PR-2026-07-30].
- • The Q2 print exposed material execution pressure: total revenue fell 3%, RUCONEST revenue fell 10%, operating profit declined sharply, and 2026 revenue guidance was reduced by US$30m.
Catalyst clock
2026-08-07
Post-earnings guidance reset digestion
Lead driver: Sentiment · See AI snapshot
Momentum
65
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
62
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-3.1
Sentiment
66
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 64.5 / Value 62.0 / Sentiment 65.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-31. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$11.50
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$8.75
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$839.24M
Beta
-0.24
Shares Out
70.78M
P/E (TTM)
411.2
P/S (TTM)
3.16
P/FCF (TTM)
21.75
Rev YoY
-4.6%
EPS YoY
-66.8%
Gross Margin
+84.8%
Op Margin
+6.1%
Net Debt
-$64.09M
Current Ratio
3.01
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data